Grace Therapeutics, Inc. (GRCE) stock
Close on Nov 12, 2026Market cap $38.08MP/E –Yield –
Grace Therapeutics statistics
63 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Nov 12, 2026 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.93
- 2.29
Share statisticsIndustry
- Shares Change (YoY)
- 25.2%
- 10.9%
- Shares Change (QoQ)
- 29.3%
- 0.48%
- Float
- 13M
- 49M
- Shares Held by Insiders
- 37.8%
- 12.1%
- Shares Held by Institutions
- 18.8%
- 56.4%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- -0.95%
- -0.76%
- Short % of Float
- 12.7%
- 9.06%
- Short % of Shares Outstanding
- 7.93%
- 6.30%
- Days to Cover
- 12.33
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $5.18
- –
- 52-Week Low
- $1.67
- –
- 20-Day Moving Average
- $1.88
- –
- 50-Day Moving Average
- $2.02
- –
- 200-Day Moving Average
- $2.73
- –
- Average True Range (14)
- $0.13
- –
- Price Change (1 Week)
- 1.69%
- 1.51%
- Price Change (1 Month)
- -4.23%
- -2.37%
- Price Change (3 Months)
- -16.2%
- -21.1%
- Price Change (6 Months)
- -17.4%
- -22.8%
- Price Change (YTD)
- -47.7%
- -22.6%
- Price Change (1 Year)
- -39.7%
- -21.0%
- Price Change (3 Years)
- -15.8%
- -24.8%
- Price Change (5 Years)
- -81.4%
- -76.9%
- Price Change (10 Years)
- -97.3%
- -63.2%
- Average Volume (10 Days)
- 94,384
- –
- Average Volume (20 Days)
- 117,898
- –
- Average Volume (90 Days)
- 153,960
- –
- Relative Volume
- 0.55
- 0.80
- Relative Strength Index (14)
- 41.0
- 44.7
- Volatility (1 Year)
- 72.0%
- 80.2%
- Beta (5 Years)
- 0.94
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -36.2%
- -51.3%
- Return on Assets (ROA)
- -34.5%
- -40.7%
- Return on Invested Capital (ROIC)
- -39.3%
- -32.9%
- Return on Capital Employed (ROCE)
- -42.2%
- -38.1%
Financial positionIndustry
- Current Ratio
- 13.61
- 3.31
- Quick Ratio
- 13.20
- 2.41
EfficiencyIndustry
- Profits Per Employee
- -$4.28M
- -$683.67K
- Employee Count
- 5
- 75
- WACC
- 9.59%
- 10.0%
Income statement (TTM)Industry
- Pretax Income
- -$23.12M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $21.31M
- $16.98M
- Net Cash Per Share
- $1.01
- $0.72
- Equity (Book Value)
- $55.48M
- $52.68M
- Book Value Per Share
- $2.64
- $1.50
- Tangible Book Value
- $19.75M
- $26.74M
- Working Capital
- $20.35M
- $78.52M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -56.2%
- -21.0%
Taxes and interestIndustry
- Income Tax
- -$1.71M
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- 3.39
- 0.26
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | GRCE | S&P 500 | Difference | GRCE per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -10.4% | -2.7% | −7.7 pts | ||
| 3 months | -13.8% | -1.7% | −12.1 pts | ||
| Year to date | -47.7% | +11.9% | −59.6 pts | ||
| 1 year | -40.3% | +12.0% | −52.2 pts | ||
| 3 years | -18.6% | +78.2% | −96.8 pts | -6.6% | +21.2% |
| 5 years | -81.4% | +73.2% | −154.6 pts | -28.5% | +11.6% |
| 10 years | -97.3% | +309.6% | −406.9 pts | -30.2% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M GRCE shares were sold short on Oct 30, 2026, down 1.0% from the previous report, or 12.74% of the shares available to trade. At recent volumes it would take 12.3 days to buy them back. Over the last 20 sessions, 37.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,667,462 | -1.0% | 135,240 | 12.3 |
| Oct 15, 2026 | 1,683,516 | -2.2% | 108,624 | 15.5 |
| Sep 30, 2026 | 1,721,067 | -2.5% | 90,442 | 19.0 |
| Sep 15, 2026 | 1,765,202 | +11.3% | 206,110 | 8.6 |
| Aug 31, 2026 | 1,586,005 | -2.3% | 86,742 | 18.3 |
| Aug 14, 2026 | 1,623,570 | +2.1% | 205,010 | 7.9 |
| Jul 31, 2026 | 1,589,555 | -2.6% | 280,528 | 5.7 |
| Jul 15, 2026 | 1,631,403 | -4.3% | 178,144 | 9.2 |
| Jun 30, 2026 | 1,705,143 | -10.4% | 336,901 | 5.1 |
| Jun 15, 2026 | 1,902,823 | -5.6% | 273,941 | 7.0 |
| May 29, 2026 | 2,015,007 | -4.0% | 300,478 | 6.7 |
| May 15, 2026 | 2,098,572 | -4.6% | 477,206 | 4.4 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?